Industry Supported Sessions

Monday, November 2, 2015​

Symposium Suppo​​​rted by Genzyme, a Sanofi company.jpg

​​Dat​e and Time: Monday, November 2, 2015, 13:00 - 14:30

Location​​: Parque Hall 

Symposia Title: Life-Saving Biotherapies for the Neurologists​ 

13:00 – 13:05      Workshop Introduction 

Dr. Juan Politei, Argentina

13:05 – 13:25      Painful neuropathy and incipient nephropathy: could it be Fabry disease? 

Dr Max Hilz, Germany

13:25 – 13:45      Fabry disease: the enemy with multiple faces 

Dr. Juan Politei, Argentina

13:45 – 14:10      Pompe – a treatable disease under recognized 

Dr. Alberto Dubrovsky, Argentina

14:10 – 14:25      Q&A

14:25 – 14:30      Closing remarks 

Dr. Juan Politei, Argentina

*********************************************************************************************************

Symposium Suppo​​​rted by ​​

Dat​e and Time: Monday, November 2, 2015, 13:00 - 14:30

Location​​: Polo Hall 

​Symposia Title: Diagnosing TTR-FAP* at the Earliest Stage: Making a Difference in a Fatal Hereditary Polyneuropathy 

Chair: Alejandra González-Duarte (Mexico)​

12.45     Lunch   

13.00     Welcome 

Alejandra González-Duarte, Mexico

13.10     TTR-FAP: The rare disease that neurologists may not know about 

Fabio Barroso, Argentina

13.30     Avoiding the pitfalls of misdiagnosing a fatal polyneuropathy: Case-based presentations 

Steven Vargas, Mexico; Marcelo Rugiero, Argentina

14.00     Optimizing care to achieve the earliest diagnosis of TTR-FAP 

Alejandra González-Duarte, Mexico

14.20     Panel discussion - Moderated by 

Alejandra González-Duarte, Mexico

14.30     Close     

*********************************************************************************************************

Tuesday, November 3, 2015​

Symposium Suppo​​​rted by ​​​Biogen.jpg

Dat​e and Time: Tuesday, November 3, 2015, 12:45 - 14:15

Location​​​: Vitacura Hall

​Symposia Title: Optimizing MS management in an age of increasing choice

Tailoring choice: A drug for each patient at the right time 

Prof Hans Peter Hartung, Germany

Dimethyl Fumarate – A Novel Oral Option for Treating MS

Prof Xavier Montalban, Spain

Natalizumab: Effective use for the right patient 

Prof Patrick Vermersch, France

PR-fampridine: Quality of life in the ENABLE study 

Prof Thomas Berger, Austria

*********************************************************************************************************

Symposium Suppo​​​rted by ​​Kedrion Biopharma.jpg

Dat​e and Time: Tuesday, November 3, 2015, 12:45 - 14:15

Location​​: Parque Hall

​Symposia Title: Immunoglobulins: Past, Present and Future

Chairs: Eduardo Nobile-Orazio, Milan, Italy

How to treat patients with CIDP? 

Eduardo Nobile-Orazio, Milan, Italy

Effective treatment in GBS 

David Cornblath, Baltimore, USA

Myastenic crisis Management 

Josè Gabriel Cea, Santiago, Chile

*********************************************************************************************************

Wednesday, November 4, 2015​

Symposium Suppo​​​rted by Novartis.jpg

Dat​e and Time: Wednesday, November 4, 2015, 12:45 - 13:45

Location​​: Vitacura Hal

l

​Symposia Title: Novel Approaches to Multiple Sclerosis 

Treatment 

12:45 – 12:50    Welcome Address 

Professor Jorge Barahona Strauch (Chile)

12:50 – 13:05      Emerging Treatments in Multiple Sclerosis                                     Professor William Carroll (Australia)

13:05 – 13:30      Monitoring Multiple Sclerosis Patients Based on NEDA-4

Professor Ludwig Kappos (Switzerland)

​13:30 -13:45        Q&A and Close

Moderated by Professor William Carroll

                ​


Keep Me Updated